PENUMBRA INC (PEN) Stock Fundamental Analysis
USA - NYSE:PEN - US70975L1070 - Common Stock
249 USD
-4.84 (-1.91%)
249 USD
0 (0%)
Taking everything into account, PEN scores 6 out of 10 in our fundamental rating. PEN was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While PEN has a great health rating, its profitability is only average at the moment. PEN is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, PEN could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year PEN was profitable.
PEN had a positive operating cash flow in the past year.
In multiple years PEN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PEN reported negative operating cash flow in multiple years.
1.2 Ratios
PEN has a Return On Assets of 8.82%. This is amongst the best in the industry. PEN outperforms 92.67% of its industry peers.
PEN's Return On Equity of 11.41% is amongst the best of the industry. PEN outperforms 88.48% of its industry peers.
With an excellent Return On Invested Capital value of 7.05%, PEN belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
PEN had an Average Return On Invested Capital over the past 3 years of 2.98%. This is significantly below the industry average of 8.89%.
The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.05%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 11.41% | ||
| ROIC | 7.05% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 11.54%, PEN belongs to the top of the industry, outperforming 86.39% of the companies in the same industry.
In the last couple of years the Profit Margin of PEN has declined.
Looking at the Operating Margin, with a value of 12.45%, PEN belongs to the top of the industry, outperforming 80.10% of the companies in the same industry.
PEN's Operating Margin has declined in the last couple of years.
PEN's Gross Margin of 66.47% is fine compared to the rest of the industry. PEN outperforms 71.20% of its industry peers.
PEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.45% | ||
| PM (TTM) | 11.54% | ||
| GM | 66.47% |
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
2. Health
2.1 Basic Checks
PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PEN has been reduced compared to 1 year ago.
The number of shares outstanding for PEN has been increased compared to 5 years ago.
Compared to 1 year ago, PEN has an improved debt to assets ratio.
2.2 Solvency
PEN has an Altman-Z score of 17.15. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
PEN has a Altman-Z score of 17.15. This is amongst the best in the industry. PEN outperforms 94.24% of its industry peers.
The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
PEN's Debt to FCF ratio of 0.15 is amongst the best of the industry. PEN outperforms 94.24% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that PEN is not too dependend on debt financing.
The Debt to Equity ratio of PEN (0.02) is better than 70.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Altman-Z | 17.15 |
ROIC/WACC0.82
WACC8.65%
2.3 Liquidity
PEN has a Current Ratio of 6.75. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN has a Current ratio of 6.75. This is amongst the best in the industry. PEN outperforms 84.82% of its industry peers.
A Quick Ratio of 4.04 indicates that PEN has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.04, PEN is doing good in the industry, outperforming 75.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.75 | ||
| Quick Ratio | 4.04 |
3. Growth
3.1 Past
PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.53%, which is quite impressive.
The Earnings Per Share has been growing by 24.23% on average over the past years. This is a very strong growth
PEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.92%.
The Revenue has been growing by 16.89% on average over the past years. This is quite good.
EPS 1Y (TTM)41.53%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%34.37%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%13.38%
3.2 Future
The Earnings Per Share is expected to grow by 24.75% on average over the next years. This is a very strong growth
PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.06% yearly.
EPS Next Y31.21%
EPS Next 2Y33.12%
EPS Next 3Y30.65%
EPS Next 5Y24.75%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.06%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 70.94, which means the current valuation is very expensive for PEN.
Based on the Price/Earnings ratio, PEN is valued a bit cheaper than 65.97% of the companies in the same industry.
PEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.40.
The Price/Forward Earnings ratio is 48.96, which means the current valuation is very expensive for PEN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 68.59% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. PEN is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.94 | ||
| Fwd PE | 48.96 |
4.2 Price Multiples
65.97% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
PEN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PEN is cheaper than 73.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.08 | ||
| EV/EBITDA | 52.18 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
PEN's earnings are expected to grow with 30.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.27
PEG (5Y)2.93
EPS Next 2Y33.12%
EPS Next 3Y30.65%
5. Dividend
5.1 Amount
PEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
249
-4.84 (-1.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.23%
Inst Owner Change-0.02%
Ins Owners3.71%
Ins Owner Change8.97%
Market Cap9.71B
Analysts82.5
Price Target318.84 (28.05%)
Short Float %5.27%
Short Ratio4.12
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.74%
Min EPS beat(2)3.63%
Max EPS beat(2)23.86%
EPS beat(4)4
Avg EPS beat(4)14.23%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)16.41%
EPS beat(12)12
Avg EPS beat(12)26.69%
EPS beat(16)13
Avg EPS beat(16)15.8%
Revenue beat(2)2
Avg Revenue beat(2)2.12%
Min Revenue beat(2)1.67%
Max Revenue beat(2)2.56%
Revenue beat(4)4
Avg Revenue beat(4)1.18%
Min Revenue beat(4)0.22%
Max Revenue beat(4)2.56%
Revenue beat(8)6
Avg Revenue beat(8)0.49%
Revenue beat(12)9
Avg Revenue beat(12)0.89%
Revenue beat(16)12
Avg Revenue beat(16)1.37%
PT rev (1m)0%
PT rev (3m)-0.49%
EPS NQ rev (1m)0.6%
EPS NQ rev (3m)-4.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-1%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.94 | ||
| Fwd PE | 48.96 | ||
| P/S | 7.59 | ||
| P/FCF | 60.08 | ||
| P/OCF | 48.2 | ||
| P/B | 7.5 | ||
| P/tB | 8.67 | ||
| EV/EBITDA | 52.18 |
EPS(TTM)3.51
EY1.41%
EPS(NY)5.09
Fwd EY2.04%
FCF(TTM)4.14
FCFY1.66%
OCF(TTM)5.17
OCFY2.07%
SpS32.82
BVpS33.18
TBVpS28.73
PEG (NY)2.27
PEG (5Y)2.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 11.41% | ||
| ROCE | 10.5% | ||
| ROIC | 7.05% | ||
| ROICexc | 9.79% | ||
| ROICexgc | 11.64% | ||
| OM | 12.45% | ||
| PM (TTM) | 11.54% | ||
| GM | 66.47% | ||
| FCFM | 12.63% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexcg growth 3Y49.31%
ROICexcg growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score9
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Debt/EBITDA | 0.12 | ||
| Cap/Depr | 209.19% | ||
| Cap/Sales | 3.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 112.96% | ||
| Profit Quality | 109.42% | ||
| Current Ratio | 6.75 | ||
| Quick Ratio | 4.04 | ||
| Altman-Z | 17.15 |
F-Score9
WACC8.65%
ROIC/WACC0.82
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.53%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%34.37%
EPS Next Y31.21%
EPS Next 2Y33.12%
EPS Next 3Y30.65%
EPS Next 5Y24.75%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%13.38%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.06%
EBIT growth 1Y48.52%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year74.3%
EBIT Next 3Y39.57%
EBIT Next 5Y26.5%
FCF growth 1Y31590.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y979.8%
OCF growth 3Y160.78%
OCF growth 5Y44.6%